1. PRLog Home
  2. Business Index
  3. Pressroom Index
  4. Press Releases Home
  1. About
  2. Press Room
  3. Contact
Filter By Industry
Filter By Tag

Press Room

Nemucore Medical Innovations Press releases

1 - 10 of 10 Press Releases

Mar 25, 2014
Nemucore Medical Innovations, Inc. (NMI) is a privately-held biopharmaceutical company dedicated to the development and commercialization of targeted nanomedicines for the treatment of patients afflicted with multidrug resistant cancers.

Mar 24, 2014
Nemucore Medical Innovations, Inc., a privately-held biopharmaceutical company dedicated to the development and commercialization of targeted nanomedicines for the treatment of patients afflicted with multidrug resistant cancers, today announced its...

Mar 12, 2014
Nemucore Medical Innovations, Inc., a privately-held biopharmaceutical company dedicated to the development and commercialization of nanomedicines for the treatment of patients afflicted with multidrug resistant cancers, today announced the publication...

Feb 04, 2014
Nemucore Medical Innovations, Inc. (NMI), a privately-held biopharmaceutical company dedicated to the development and commercialization of nanomedicines for the treatment of patients afflicted with multidrug resistant cancers, today announced the...

Jan 02, 2014
Nemucore Medical Innovations, Inc. (NMI), a nanomedicine company dedicated to the development and commercialization of life-saving nanomedicines for the treatment of patients afflicted with multidrug resistant cancers, today announced the appointment of..

May 08, 2013
Nemucore Medical Innovations, Inc. (NMI) announces it has received a Phase I U43 Small Business Innovation research grant from the National Cancer Institute.

Jan 14, 2013
NMI's Co-Founder Dr. Torchilin was named the recipient of the Journal of Drug Targeting’s Lifetime Achievement Award for 2012 for his work in multifunctional pharmaceutical nanocarriers.

Apr 23, 2012
Nemucore Medical Innovations, Inc. and Massachusetts Biomedical Initiatives hosted the Central Massachusetts Legislative Caucus and Worcester City Officials at the 55 Union Street lab facilities, in Worcester, MA.

Apr 19, 2012
Nemucore Medical Innovations announces its decision to source primary tumor models from Woodland Strategic Partners of Worcester, MA.

Apr 10, 2012
Nemucore Medical Innovations hosted its first site visit with the National Cancer Institute as a member of the Centers for Cancer Nanotechnology Excellence.



RSS Feed for Nemucore Medical Innovations Press Releases